First in Human Dose Escalation of M3258 as a Single Agent and Expansion Study of M3258 in Combination With Dexamethasone
Clinical trial NCT04075721 · TERMINATED
Trial details
- NCT number
- NCT04075721
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2021-04-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.